Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 379.19B | 370.75B | 379.40B | 376.09B | 385.70B |
Gross Profit | 117.53B | 127.21B | 132.06B | 131.86B | 136.92B |
EBITDA | 33.39B | 32.84B | 37.87B | 39.60B | 41.81B |
Net Income | 13.72B | 13.71B | 17.10B | 17.90B | 20.40B |
Balance Sheet | |||||
Total Assets | 386.66B | 372.85B | 361.39B | 354.79B | 348.16B |
Cash, Cash Equivalents and Short-Term Investments | 16.34B | 16.75B | 14.11B | 19.42B | 17.30B |
Total Debt | 34.93B | 34.25B | 31.94B | 39.80B | 45.47B |
Total Liabilities | 140.34B | 136.60B | 134.04B | 140.95B | 147.60B |
Stockholders Equity | 246.32B | 236.25B | 227.35B | 213.84B | 200.56B |
Cash Flow | |||||
Free Cash Flow | 6.49B | 6.03B | 8.60B | 15.18B | 22.67B |
Operating Cash Flow | 23.12B | 21.36B | 19.87B | 25.86B | 36.55B |
Investing Cash Flow | -18.20B | -15.43B | -11.66B | -11.26B | -14.23B |
Financing Cash Flow | -5.25B | -3.29B | -13.50B | -12.48B | -14.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥162.65B | 10.94 | 1.65% | 1.84% | -3.32% | ||
61 Neutral | $17.75B | 12.51 | -5.49% | 3.06% | 1.43% | -14.10% | |
― | €319.33M | 257.68 | -0.02% | ― | ― | ― | |
79 Outperform | ¥196.04B | 11.53 | 2.92% | 6.96% | -19.43% | ||
78 Outperform | ¥129.68B | 16.27 | 2.72% | 1.81% | -7.42% | ||
67 Neutral | ¥125.85B | 8.38 | 2.50% | 4.89% | 7.47% | ||
66 Neutral | ¥33.09B | 15.80 | 1.45% | 3.11% | -5.40% |